Injection of approximately 4 ml of activated PRP (concentration and agonist not reported) into the ovaries of three subfertile women who experienced >1 year of amenorrhea (2 POF, 1 menopausal). Measurement of FSH, AMH, E2, LH and AFC pre- and post-therapy. The gene discussed is BRD2; the disease is amenorrhea.